Neogenomics Inc
NASDAQ:NEO
Neogenomics Inc
NASDAQ:NEO
Price:
8
USD
3.23%
Market Closed
Market Cap:
$1B
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
Neogenomics Inc
NASDAQ:NEO
|
US |
Balance Sheet
Balance Sheet Decomposition
Neogenomics Inc
Neogenomics Inc
Balance Sheet Decomposition is not available for
Neogenomics Inc
Neogenomics Inc
Balance Sheet
Neogenomics Inc
Neogenomics Inc
Currency: USD
| Dec-2003 | Dec-2004 | Dec-2005 | Dec-2006 | Dec-2007 | Dec-2008 | Dec-2009 | Dec-2010 | Dec-2011 | Dec-2012 | Dec-2013 | Dec-2014 | Dec-2015 | Dec-2016 | Dec-2017 | Dec-2018 | Dec-2019 | Dec-2020 | Dec-2021 | Dec-2022 | Dec-2023 | Dec-2024 | Dec-2025 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||||||||||||||||
| Cash & Cash Equivalents |
0
|
0
|
0
|
0
|
0
|
1
|
2
|
1
|
3
|
2
|
5
|
34
|
23
|
13
|
13
|
10
|
173
|
229
|
317
|
263
|
342
|
367
|
160
|
|
| Cash |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Cash Equivalents |
0
|
0
|
0
|
0
|
0
|
1
|
2
|
1
|
3
|
2
|
5
|
34
|
23
|
13
|
13
|
10
|
173
|
229
|
317
|
263
|
342
|
367
|
160
|
|
| Short-Term Investments |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
68
|
199
|
175
|
73
|
20
|
0
|
|
| Total Receivables |
0
|
0
|
1
|
2
|
3
|
3
|
5
|
5
|
8
|
14
|
19
|
21
|
49
|
56
|
60
|
77
|
94
|
109
|
114
|
122
|
131
|
151
|
159
|
|
| Accounts Receivables |
0
|
0
|
1
|
2
|
3
|
3
|
5
|
5
|
8
|
14
|
19
|
21
|
49
|
56
|
60
|
77
|
94
|
109
|
114
|
122
|
131
|
151
|
159
|
|
| Other Receivables |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Inventory |
0
|
0
|
0
|
0
|
0
|
1
|
1
|
1
|
1
|
2
|
2
|
3
|
5
|
6
|
8
|
9
|
14
|
30
|
23
|
24
|
24
|
27
|
29
|
|
| Other Current Assets |
0
|
0
|
0
|
0
|
0
|
1
|
2
|
2
|
2
|
1
|
2
|
2
|
5
|
5
|
5
|
8
|
9
|
14
|
29
|
21
|
26
|
32
|
29
|
|
| Total Current Assets |
0
|
0
|
1
|
2
|
4
|
4
|
9
|
9
|
13
|
19
|
28
|
59
|
82
|
79
|
86
|
104
|
291
|
449
|
682
|
605
|
597
|
596
|
376
|
|
| PP&E Net |
0
|
0
|
0
|
1
|
2
|
3
|
4
|
5
|
7
|
9
|
10
|
15
|
35
|
34
|
37
|
61
|
91
|
132
|
212
|
199
|
184
|
174
|
163
|
|
| PP&E Gross |
0
|
0
|
0
|
1
|
2
|
3
|
4
|
5
|
7
|
9
|
10
|
15
|
35
|
34
|
37
|
61
|
91
|
132
|
212
|
199
|
184
|
174
|
163
|
|
| Accumulated Depreciation |
0
|
0
|
0
|
1
|
1
|
2
|
3
|
5
|
7
|
10
|
15
|
20
|
27
|
27
|
41
|
50
|
69
|
93
|
110
|
132
|
158
|
190
|
209
|
|
| Intangible Assets |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
3
|
3
|
4
|
88
|
77
|
74
|
140
|
127
|
121
|
442
|
408
|
373
|
340
|
287
|
|
| Goodwill |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
3
|
146
|
147
|
147
|
198
|
199
|
211
|
527
|
523
|
523
|
523
|
524
|
|
| Note Receivable |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Long-Term Investments |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
30
|
0
|
0
|
0
|
0
|
0
|
|
| Other Long-Term Assets |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
3
|
3
|
46
|
7
|
5
|
5
|
6
|
9
|
|
| Other Assets |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
3
|
146
|
147
|
147
|
198
|
199
|
211
|
527
|
523
|
523
|
523
|
524
|
|
| Total Assets |
1
N/A
|
1
+20%
|
1
+83%
|
3
+182%
|
7
+110%
|
7
+12%
|
13
+77%
|
14
+6%
|
20
+45%
|
30
+51%
|
40
+33%
|
81
+103%
|
351
+333%
|
337
-4%
|
345
+2%
|
505
+47%
|
710
+40%
|
988
+39%
|
1 870
+89%
|
1 740
-7%
|
1 681
-3%
|
1 638
-3%
|
1 360
-17%
|
|
| Liabilities | ||||||||||||||||||||||||
| Accounts Payable |
0
|
1
|
1
|
2
|
2
|
2
|
2
|
2
|
3
|
4
|
4
|
6
|
13
|
17
|
11
|
18
|
20
|
25
|
18
|
21
|
20
|
22
|
23
|
|
| Accrued Liabilities |
0
|
0
|
0
|
0
|
1
|
1
|
2
|
2
|
3
|
4
|
3
|
5
|
14
|
13
|
16
|
28
|
32
|
41
|
63
|
62
|
74
|
78
|
64
|
|
| Short-Term Debt |
0
|
0
|
0
|
0
|
0
|
1
|
1
|
3
|
4
|
9
|
4
|
0
|
9
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Current Portion of Long-Term Debt |
0
|
0
|
0
|
0
|
0
|
1
|
2
|
2
|
2
|
2
|
3
|
3
|
5
|
9
|
9
|
14
|
10
|
3
|
1
|
0
|
0
|
201
|
0
|
|
| Other Current Liabilities |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
1
|
2
|
4
|
5
|
8
|
2
|
0
|
1
|
|
| Total Current Liabilities |
0
|
1
|
1
|
3
|
3
|
4
|
6
|
9
|
11
|
18
|
14
|
15
|
40
|
38
|
37
|
61
|
64
|
73
|
87
|
90
|
96
|
301
|
88
|
|
| Long-Term Debt |
0
|
0
|
0
|
0
|
1
|
1
|
2
|
1
|
3
|
3
|
3
|
5
|
57
|
97
|
96
|
98
|
95
|
169
|
533
|
535
|
538
|
340
|
342
|
|
| Deferred Income Tax |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
1
|
16
|
15
|
7
|
23
|
16
|
5
|
56
|
35
|
24
|
22
|
18
|
|
| Other Liabilities |
1
|
0
|
1
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
3
|
28
|
46
|
86
|
82
|
81
|
73
|
75
|
|
| Total Liabilities |
1
N/A
|
1
+11%
|
2
+110%
|
3
+48%
|
4
+35%
|
6
+38%
|
7
+26%
|
11
+44%
|
14
+34%
|
21
+48%
|
18
-13%
|
21
+14%
|
113
+447%
|
151
+33%
|
140
-7%
|
185
+32%
|
202
+9%
|
294
+45%
|
762
+159%
|
742
-3%
|
740
0%
|
736
-1%
|
523
-29%
|
|
| Equity | ||||||||||||||||||||||||
| Common Stock |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
29
|
23
|
33
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Retained Earnings |
9
|
10
|
11
|
11
|
15
|
16
|
18
|
22
|
23
|
23
|
21
|
19
|
22
|
53
|
58
|
51
|
11
|
7
|
15
|
159
|
247
|
326
|
434
|
|
| Additional Paid In Capital |
9
|
10
|
10
|
11
|
17
|
17
|
24
|
25
|
29
|
32
|
42
|
80
|
232
|
216
|
230
|
372
|
520
|
701
|
1 124
|
1 161
|
1 190
|
1 228
|
1 270
|
|
| Other Equity |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
2
|
0
|
1
|
4
|
2
|
0
|
0
|
|
| Total Equity |
0
N/A
|
0
N/A
|
1
-150%
|
0
N/A
|
2
+2 200%
|
2
-35%
|
6
+273%
|
3
-45%
|
6
+90%
|
9
+56%
|
22
+136%
|
60
+178%
|
238
+294%
|
187
-22%
|
205
+10%
|
320
+57%
|
507
+58%
|
694
+37%
|
1 108
+60%
|
998
-10%
|
942
-6%
|
902
-4%
|
837
-7%
|
|
| Total Liabilities & Equity |
1
N/A
|
1
+20%
|
1
+83%
|
3
+182%
|
7
+110%
|
7
+12%
|
13
+77%
|
14
+6%
|
20
+45%
|
30
+51%
|
40
+33%
|
81
+103%
|
351
+333%
|
337
-4%
|
345
+2%
|
505
+47%
|
710
+40%
|
988
+39%
|
1 870
+89%
|
1 740
-7%
|
1 681
-3%
|
1 638
-3%
|
1 360
-17%
|
|
| Shares Outstanding | ||||||||||||||||||||||||
| Common Shares Outstanding |
18
|
22
|
23
|
27
|
31
|
32
|
37
|
37
|
43
|
45
|
49
|
60
|
76
|
79
|
81
|
95
|
105
|
112
|
124
|
127
|
127
|
128
|
129
|
|
| Preferred Shares Outstanding |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
7
|
7
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
Switch to:
Switch to:
See Also
Discover More
